[go: up one dir, main page]

PE20081160A1 - Arilsulfonil-pirrolidinas como inhibidores 5-ht6 - Google Patents

Arilsulfonil-pirrolidinas como inhibidores 5-ht6

Info

Publication number
PE20081160A1
PE20081160A1 PE2007001539A PE2007001539A PE20081160A1 PE 20081160 A1 PE20081160 A1 PE 20081160A1 PE 2007001539 A PE2007001539 A PE 2007001539A PE 2007001539 A PE2007001539 A PE 2007001539A PE 20081160 A1 PE20081160 A1 PE 20081160A1
Authority
PE
Peru
Prior art keywords
alkyl
alcoxy
benzenosulfonyl
pyrrolidin
pyrrolidine
Prior art date
Application number
PE2007001539A
Other languages
English (en)
Inventor
Francisco Javier Lopez-Tapia
Lowrie
Dov Nitzan
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20081160A1 publication Critical patent/PE20081160A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

SE REFIERE A UN COMPUESTO DERIVADO DE PIRROLIDINA DE FORMULA I, DONDE m ES 0-4; n ES 0-2; Ar ES FENILO, INDONILO, PIRIMIDINILO, ENTRE OTROS; R1 ES H, ALQUILO C1-C6, HETERO-(ALQUILO C1-C6), -(CH2)p-X-(CH2)q-Ra; X ES -C(O)-, -SO2-; p Y q SON 0-1; Ra ES ALQUILO C1-C6, ALCOXI C1-C6, N-ALQUIL C1-C6-AMINO, ENTRE OTROS; R2 ES HALOGENO, ALCOXI C1-C6, NITRO, HIDROXI-(ALCOXI C1-C6), ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 3-[4-(3-FLUOR-BENCENOSULFONIL)-2-METOXI-FENIL]PIRROLIDINA; 5-BENCENOSULFONIL-2-PIRROLIDIN-3-IL-FENOL; 4-(4-(S)-PIRROLIDIN-3-IL-BENCENOSULFONIL)-FENOL; ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO O PREVENCION TRANSTORNOS NEUROLOGICOS COMO PSICOSIS, ESQUIZOFRENIA, ENTRE OTROS
PE2007001539A 2006-11-09 2007-11-08 Arilsulfonil-pirrolidinas como inhibidores 5-ht6 PE20081160A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85810606P 2006-11-09 2006-11-09

Publications (1)

Publication Number Publication Date
PE20081160A1 true PE20081160A1 (es) 2008-08-15

Family

ID=39023536

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001539A PE20081160A1 (es) 2006-11-09 2007-11-08 Arilsulfonil-pirrolidinas como inhibidores 5-ht6

Country Status (18)

Country Link
US (1) US7776910B2 (es)
EP (1) EP2081890B1 (es)
JP (1) JP2010509266A (es)
KR (1) KR20090079259A (es)
CN (1) CN101573332A (es)
AR (1) AR063576A1 (es)
AT (1) ATE495153T1 (es)
AU (1) AU2007316688A1 (es)
BR (1) BRPI0718584A2 (es)
CA (1) CA2667710A1 (es)
CL (1) CL2007003190A1 (es)
DE (1) DE602007011962D1 (es)
ES (1) ES2358549T3 (es)
IL (1) IL198322A0 (es)
MX (1) MX2009004947A (es)
PE (1) PE20081160A1 (es)
TW (1) TW200827337A (es)
WO (1) WO2008055847A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8987307B2 (en) 2011-03-03 2015-03-24 Hoffmann-La Roche Inc. 3-amino-pyridines as GPBAR1 agonists
CN104203935A (zh) 2012-04-04 2014-12-10 霍夫曼-拉罗奇有限公司 作为gpbar1调节剂的1，2-哒嗪，1，6-哒嗪或嘧啶-苯甲酰胺衍生物
CN104557726B (zh) * 2013-10-19 2019-05-24 广东东阳光药业有限公司 芳杂环类衍生物及其在药物上的应用
CN104725295B (zh) 2013-12-20 2019-05-24 广东东阳光药业有限公司 芳杂环类衍生物及其在药物上的应用
CN105566182B (zh) * 2016-02-24 2018-02-13 苏州天马精细化学品股份有限公司 一种2‑氨基‑4‑（乙磺酰基）苯酚的合成方法
CN108689904B (zh) * 2017-04-12 2022-06-17 轩竹生物科技股份有限公司 手性杂环叔醇中间体的制备方法及其应用
CN109232362B (zh) * 2017-07-10 2022-12-27 广东东阳光药业有限公司 芳杂环类衍生物及其在药物上的应用
CN111372579B (zh) * 2017-10-30 2023-08-22 神经孔疗法股份有限公司 取代的苯基磺酰基苯基三唑硫酮和其用途
CN109912487B (zh) * 2019-03-25 2023-01-10 山东理工大学 一种合成1-对甲苯磺酰基-2-乙烯基-1氢-吡咯的方法
TW202128161A (zh) 2019-10-18 2021-08-01 美國加利福尼亞大學董事會 用於靶向病原性血管之化合物及方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69906397T2 (de) * 1998-01-16 2004-02-19 F. Hoffmann-La Roche Ag Benzosulfonderivate
PE20020063A1 (es) 2000-06-20 2002-01-30 Upjohn Co Bis-arilsulfonas como ligandos del receptor de 5-ht
US20040014966A1 (en) * 2000-06-20 2004-01-22 Jacobsen Eric Jon Bis-arylsulfones
PL376479A1 (en) 2002-10-18 2005-12-27 F.Hoffmann-La Roche Ag 4-piperazinyl benzenesulfonyl indoles with 5-ht6 receptor affinity
BRPI0407618A (pt) * 2003-02-21 2006-02-21 Pfizer derivados de tiazole amino substituidos com cicloalquilo contendo n e composições farmacêuticas para inibição da proliferação celular e métodos para a sua utilização
WO2005014578A1 (en) 2003-08-08 2005-02-17 Glaxo Group Limited Phenylsulfonyl compounds as antipsychotic agents
KR20080034497A (ko) * 2005-08-15 2008-04-21 와이어쓰 5-히드록시트립타민-6 리간드로서의 아지닐-3-설포닐인다졸유도체
NZ572761A (en) * 2006-04-19 2011-09-30 Abbott Gmbh & Co Kg Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor

Also Published As

Publication number Publication date
US7776910B2 (en) 2010-08-17
WO2008055847A1 (en) 2008-05-15
AU2007316688A1 (en) 2008-05-15
EP2081890A1 (en) 2009-07-29
DE602007011962D1 (en) 2011-02-24
CN101573332A (zh) 2009-11-04
ATE495153T1 (de) 2011-01-15
KR20090079259A (ko) 2009-07-21
JP2010509266A (ja) 2010-03-25
TW200827337A (en) 2008-07-01
AR063576A1 (es) 2009-02-04
BRPI0718584A2 (pt) 2014-03-11
MX2009004947A (es) 2009-05-19
CL2007003190A1 (es) 2008-06-27
ES2358549T3 (es) 2011-05-11
US20080167361A1 (en) 2008-07-10
CA2667710A1 (en) 2008-05-15
IL198322A0 (en) 2010-02-17
EP2081890B1 (en) 2011-01-12

Similar Documents

Publication Publication Date Title
PE20081160A1 (es) Arilsulfonil-pirrolidinas como inhibidores 5-ht6
PE20070136A1 (es) COMPUESTOS DERIVADOS DE N-(PIRIDIN-2-IL)-SULFONAMIDA COMO INHIBIDORES DE LA ENZIMA 11-beta-HIDROXIESTEROIDE DESHIDROGENASA HUMANA TIPO 1
PE20140192A1 (es) Derivados de bencimidazol como inhibidores de cinasa pi3
PE20060525A1 (es) Compuestos heterociclicos como inhibidores de cetp
ATE517882T1 (de) Chinolinderivate
PE20080359A1 (es) Compuestos de benzoxazol y benzotiazol 6-0-sustituidos y metodos de inhibicion de la senalizacion de csf-1r
PE20060777A1 (es) Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
PE20060150A1 (es) Antagonistas de cgrp seleccionados, composiciones farmaceuticas y procedimiento para su preparacion
MX2009006195A (es) Compuestos basados en 4-fenil-6-(2,2,2-trifluoro-1-feniletoxi)piri midina y metodos de su uso.
TNSN07022A1 (fr) Derives de pyridine
MA31419B1 (fr) Derives de pyridine
NZ592425A (en) Isoindoline compounds for use in the treatment of cancer
MXPA05012466A (es) Derivados de quinolina como inhibidores de fosfodiesterasa.
MX2009012390A (es) Uso de compuestos de 4-(pirrolidin-1-il)quinolina para exterminar microorganismos clinicamente latentes.
PE20090210A1 (es) Compuestos derivados de pirazolo pirimidina como inhibidores de jak quinasa
MY157116A (en) Novel seh inhibitors and their use
PE20090435A1 (es) Inhibidores de tetrahidropiranocromeno de gamma secretasa
MXPA06012640A (es) Compuestos de morfolina.
MX2009009238A (es) Nuevos inhibidores de fosfodiesterasa.
TW200716547A (en) Piperidin-4-yl-amide derivatives
TW200612936A (en) Indole derivatives
ATE435223T1 (de) Pyrimidin-, chinazolin-, pteridin- und triazinderivate
ATE368666T1 (de) Pyrazolopyrimidinone und ihre verwendung als pde inhibitoren
TW200728291A (en) Amide derivatives
IL195016A0 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives

Legal Events

Date Code Title Description
FD Application declared void or lapsed